-
1.Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate 失效
标题翻译: (S) - (+) - 氯吡格雷硫酸氢盐的多晶型物和无定形形式公开(公告)号:US07872019B2
公开(公告)日:2011-01-18
申请号:US10548712
申请日:2003-03-12
申请人: Braj B. Lohray , Vidya B. Lohray , Bipin Pandey , Mayank G. Dave
发明人: Braj B. Lohray , Vidya B. Lohray , Bipin Pandey , Mayank G. Dave
IPC分类号: A61K31/44 , C07D515/02
CPC分类号: C07D495/04
摘要: The present invention relates to new polymorphs of S-(+)-Clopidogrel bisulfate and a process for preparing the same.
摘要翻译: 本发明涉及S - (+) - 氯吡格雷硫酸氢盐的新型多晶型物及其制备方法。
-
2.Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine 失效
标题翻译: 杂环化合物的制备方法和含有它们的药物组合物及其在医药中的应用公开(公告)号:US07348342B2
公开(公告)日:2008-03-25
申请号:US10509894
申请日:2003-04-01
IPC分类号: A61K31/444 , A61K31/4439 , A61K31/426 , A61K31/421 , A61K31/42 , A61K31/4155 , A61K31/415 , C07D213/22 , C07D401/04 , C07D277/34 , C07D263/38 , C07D261/12 , C07D231/10 , C07D231/12
CPC分类号: C07D409/04 , C07D213/61 , C07D231/12 , C07D261/08 , C07D261/10 , C07D263/38 , C07D277/34 , C07D307/58 , C07D401/04 , Y02P20/582
摘要: We describe substituted benzenesulfoximine compounds having anti-inflammatory activity, processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of inflammatory diseases.
摘要翻译: 我们描述具有抗炎活性的取代苯磺酰亚胺化合物,其制备方法,含有它们的药物组合物及其在治疗炎性疾病中的用途。
-
公开(公告)号:US20090275565A1
公开(公告)日:2009-11-05
申请号:US12458315
申请日:2009-07-08
申请人: Braj B. Lohray , Vidya B. Lohray , Mukul R. Jain , Sujay Basu , Harikishore Pingali , Saurin K. Raval , Preoti S. Raval
发明人: Braj B. Lohray , Vidya B. Lohray , Mukul R. Jain , Sujay Basu , Harikishore Pingali , Saurin K. Raval , Preoti S. Raval
IPC分类号: A61K31/5415 , C07D413/04 , A61K31/422 , A61K31/4709 , C07D279/22
CPC分类号: C07D207/325 , C07C43/23 , C07D209/08 , C07D209/86 , C07D213/30 , C07D215/14 , C07D235/06 , C07D239/91 , C07D261/08 , C07D265/38 , C07D279/16 , C07D405/04 , C07D409/04 , C07D413/04
摘要: The present invention relates to novel substituted aralkyl derivatives of the general formula (I) and (IIIa), their derivatives, their analogs, their tautomeric forms, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates, pharmaceutical compositions containing them, use of these compounds in medicine and the intermediates involved in their preparation.
摘要翻译: 本发明涉及通式(I)和(IIIa)的新型取代芳烷基衍生物,其衍生物,其类似物,其互变异构形式,其药学上可接受的盐,其药学上可接受的溶剂合物,含有它们的药物组合物,这些化合物的用途 在医药和中间体参与其准备。
-
-